Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

PTC Therapeutics, Inc. (PTCT) vs Travere Therapeutics, Inc. (TVTX)

PTC Therapeutics, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. PTC Therapeutics, Inc. and Travere Therapeutics, Inc. are of similar size ($5.7B and $5.2B). Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 77.1% against −42.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −7.35%) and the higher return on invested capital (15.2% vs −18.3%). Across the 18 metrics below, PTC Therapeutics, Inc. leads on 12 and Travere Therapeutics, Inc. on 6.

Valuation

Metric PTCT TVTX Biotechnology median
P/E n/m n/m 7.88
P/S 5.16 9.40 11.47
P/B n/m 226.59 2.52
Price to free cash flow n/m 383.94 21.16
EV/EBITDA 36.15 281.89 0.74
EV/Sales 5.83 9.59 10.73
Earnings yield (0.78%) (0.76%) (28.84%)
Free cash flow yield (5.77%) 0.26% (23.03%)

Profitability

Metric PTCT TVTX Biotechnology median
Gross margin 92.99% 98.60% 65.16%
Operating margin 12.45% (6.84%) 0.00%
Net margin (3.80%) (7.35%) 0.00%
Free cash flow margin (29.76%) 2.56% 0.00%
Return on equity 20.64% (151.79%) (57.72%)
Return on assets (1.30%) (6.42%) (49.22%)
Return on invested capital 15.16% (18.31%) 0.00%

Growth

Metric PTCT TVTX Biotechnology median
Revenue growth (TTM) (42.84%) 77.12% 5.64%
EPS growth (last fiscal year) 264.48% 92.89% —
Revenue growth, 5-year CAGR 35.37% 19.87% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTCT TVTX Biotechnology median
Debt to equity (17.61) 24.58 0.00
Current ratio 3.39 4.05 4.73
Net debt to EBITDA 0.73 2.27 0.96

Dividend

Metric PTCT TVTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PTCT TVTX Biotechnology median
Market cap 5.20b 5.66b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack